Real-time enrollment status for this prostate adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 5:27 AM UTC
| NCT Number | NCT06330805 |
| Recruiting Status | Recruiting |
| Condition | Prostate Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 70 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | March 9, 2026 (Mar 9, 2026) |
As of July 20, 2026: Clinical trial NCT06330805 is currently recruiting participants. This phase2 study for prostate adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06330805 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06330805 was last updated Mar 9, 2026 (March 9, 2026). HelloStudys verifies this status automatically.